WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ABCL

Based on 2 analysts offering 12 month price targets for Abcellera Biologics Inc

Min Forecast
$5.00+91.57%
Avg Forecast
$7.50+187.36%
Max Forecast
$10.00+283.14%

Should I buy or sell ABCL stock?

Based on 2 analysts offering ratings for Abcellera Biologics Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ABCL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ABCL as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ABCL stock forecasts and price targets.

ABCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-16
lockedlocked$00.00+00.00%2025-02-28

1 of 1

ABCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$2.61$7.50+187.36%Strong Buy
XNCR$11.02$31.25+183.58%Strong Buy
BCAX$14.37$24.00+67.04%Buy
LENZ$28.52$42.67+49.63%Strong Buy
DAWN$7.78$31.00+298.46%Strong Buy
View Top Biotech Stocks

Abcellera Biologics Stock Forecast FAQ

Is Abcellera Biologics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.

Out of 2 analysts, 2 (100%) are recommending ABCL as a Strong Buy, 0 (0%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.

What is ABCL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $7.50, with the highest ABCL stock price forecast at $10.00 and the lowest ABCL stock price forecast at $5.00.

On average, Wall Street analysts predict that Abcellera Biologics's share price could reach $7.50 by Apr 16, 2026. The average Abcellera Biologics stock price prediction forecasts a potential upside of 187.36% from the current ABCL share price of $2.61.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.